{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:04:40Z","timestamp":1792829080027,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:00:00Z","timestamp":1613865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["13\/IA\/1891"],"award-info":[{"award-number":["13\/IA\/1891"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["11\/TIDA\/B1988"],"award-info":[{"award-number":["11\/TIDA\/B1988"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SFI\/14\/ADV\/RC2721"],"award-info":[{"award-number":["SFI\/14\/ADV\/RC2721"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["17\/TIDA\/5002"],"award-info":[{"award-number":["17\/TIDA\/5002"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/RC\/3948"],"award-info":[{"award-number":["16\/RC\/3948"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001590","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"European Commission Seventh Framework Programme for Research and Technological Development Health","doi-asserted-by":"publisher","award":["602130"],"award-info":[{"award-number":["602130"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ymthe.2021.02.021","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T06:51:48Z","timestamp":1613890308000},"page":"2041-2052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy"],"prefix":"10.1016","volume":"29","author":[{"given":"Cristina R.","family":"Reschke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz F.A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamshidhar R.","family":"Vangoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenton L.","family":"Cavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh M.C.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Sanz-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasia","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan M.","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor","family":"R\u00fcber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen H.M.","family":"Prehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeroen","family":"Pasterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6237-9632","authenticated-orcid":false,"given":"David C.","family":"Henshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2021.02.021_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJMra1705346","article-title":"Treating disease at the RNA level with oligonucleotides","volume":"380","author":"Levin","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.02.021_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nbt.3784","article-title":"Oligonucleotide therapies for disorders of the nervous system","volume":"35","author":"Khorkova","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2021.02.021_bib3","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.02.021_bib4","doi-asserted-by":"crossref","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2021.02.021_bib5","doi-asserted-by":"crossref","first-page":"107605","DOI":"10.1016\/j.neuropharm.2019.04.011","article-title":"The holy grail of epilepsy prevention: preclinical approaches to antiepileptogenic treatments","volume":"167","author":"L\u00f6scher","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ymthe.2021.02.021_bib6","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S1474-4422(16)30246-0","article-title":"MicroRNAs in epilepsy: pathophysiology and clinical utility","volume":"15","author":"Henshall","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2021.02.021_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuron.2012.07.005","article-title":"MicroRNAs shape the neuronal landscape","volume":"75","author":"McNeill","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2021.02.021_bib8","doi-asserted-by":"crossref","first-page":"e35921","DOI":"10.1371\/journal.pone.0035921","article-title":"Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis","volume":"7","author":"McKiernan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.02.021_bib9","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1093\/hmg\/ddq311","article-title":"Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration","volume":"19","author":"H\u00e9bert","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2021.02.021_bib10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1244193","article-title":"MicroRNA-128 governs neuronal excitability and motor behavior in mice","volume":"342","author":"Tan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.02.021_bib11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nm.2834","article-title":"Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects","volume":"18","author":"Jimenez-Mateos","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.02.021_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.omtn.2016.11.002","article-title":"Potent anti-seizure effects of locked nucleic acid antagomirs targeting miR-134 in multiple mouse and rat models of epilepsy","volume":"6","author":"Reschke","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2021.02.021_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fncel.2019.00145","article-title":"Silencing microRNA-134 alleviates hippocampal damage and occurrence of spontaneous seizures after intraventricular kainic acid-induced status epilepticus in rats","volume":"13","author":"Gao","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ymthe.2021.02.021_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nature04367","article-title":"A brain-specific microRNA regulates dendritic spine development","volume":"439","author":"Schratt","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.021_bib15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nature09271","article-title":"A novel pathway regulates memory and plasticity via SIRT1 and miR-134","volume":"466","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.021_bib16","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/cercor\/bhq262","article-title":"Stage-specific modulation of cortical neuronal development by Mmu-miR-134","volume":"21","author":"Gaughwin","year":"2011","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.ymthe.2021.02.021_bib17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature06783","article-title":"LNA-mediated microRNA silencing in non-human primates","volume":"452","author":"Elm\u00e9n","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.021_bib18","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s00429-014-0798-5","article-title":"Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in\u00a0vivo and protect against pilocarpine-induced status epilepticus","volume":"220","author":"Jimenez-Mateos","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.ymthe.2021.02.021_bib19","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1093\/nar\/gkq457","article-title":"Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates","volume":"38","author":"Straarup","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.02.021_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"van Vliet","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2021.02.021_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrneurol.2010.74","article-title":"Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury","volume":"6","author":"Shlosberg","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2021.02.021_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ebiom.2019.04.054","article-title":"Early blood-brain barrier dysfunction predicts neurological outcome following aneurysmal subarachnoid hemorrhage","volume":"43","author":"Lublinsky","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2021.02.021_bib23","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1093\/brain\/awy242","article-title":"Evidence for peri-ictal blood-brain barrier dysfunction in patients with epilepsy","volume":"141","author":"R\u00fcber","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2021.02.021_bib24","doi-asserted-by":"crossref","first-page":"17486","DOI":"10.1038\/srep17486","article-title":"microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus","volume":"5","author":"Jimenez-Mateos","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2021.02.021_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.eplepsyres.2012.10.006","article-title":"Spatio-temporally restricted blood-brain barrier disruption after intra-amygdala kainic acid-induced status epilepticus in mice","volume":"103","author":"Michalak","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymthe.2021.02.021_bib26","doi-asserted-by":"crossref","first-page":"e1500472","DOI":"10.1126\/sciadv.1500472","article-title":"Autoregulated paracellular clearance of amyloid-\u03b2 across the blood-brain barrier","volume":"1","author":"Keaney","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2021.02.021_bib27","first-page":"571","article-title":"Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice","volume":"118","author":"Li","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.02.021_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/bs.pbr.2016.04.012","article-title":"Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy","volume":"226","author":"Jiang","year":"2016","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ymthe.2021.02.021_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.eplepsyres.2004.02.003","article-title":"Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility","volume":"58","author":"Buono","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymthe.2021.02.021_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0920-1211(97)00092-2","article-title":"Inhibition of pentylenetetrazol-induced seizures in rats by prostaglandin D2","volume":"30","author":"Akarsu","year":"1998","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymthe.2021.02.021_bib31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1194\/jlr.M070532","article-title":"Excitotoxicity-induced prostaglandin D2 production induces sustained microglial activation and delayed neuronal death","volume":"58","author":"Iwasa","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.ymthe.2021.02.021_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1471-4159.2004.02870.x","article-title":"Prostaglandin D2 mediates neuronal protection via the DP1 receptor","volume":"92","author":"Liang","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2021.02.021_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.celrep.2016.08.074","article-title":"MicroRNA-mediated downregulation of the potassium channel Kv4.2 contributes to seizure onset","volume":"17","author":"Gross","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2021.02.021_bib34","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/epi.14475","article-title":"Spared CA1 pyramidal neuron function and hippocampal performance following antisense knockdown of microRNA-134","volume":"59","author":"Morris","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymthe.2021.02.021_bib35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1126\/science.aaf8995","article-title":"Activity-dependent spatially localized miRNA maturation in neuronal dendrites","volume":"355","author":"Sambandan","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.02.021_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuron.2008.04.002","article-title":"Astrocytes in the epileptic brain","volume":"58","author":"Wetherington","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2021.02.021_bib37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2021.02.021_bib38","doi-asserted-by":"crossref","first-page":"72748","DOI":"10.18632\/oncotarget.20292","article-title":"MicroRNA-134 plasma levels before and after treatment with valproic acid for epilepsy patients","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2021.02.021_bib39","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/s41598-017-01947-2","article-title":"\u201cTORNADO\u201d \u2013 Theranostic One-Step RNA Detector; microfluidic disc for the direct detection of microRNA-134 in plasma and cerebrospinal fluid","volume":"7","author":"McArdle","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2021.02.021_bib40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrneurol.2014.43","article-title":"Gene therapy in epilepsy\u2014is it time for clinical trials?","volume":"10","author":"Kullmann","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2021.02.021_bib41","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2021.02.021_bib42","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.cell.2010.11.021","article-title":"Functional overlap and regulatory links shape genetic interactions between signaling pathways","volume":"143","author":"van Wageningen","year":"2010","journal-title":"Cell"},{"issue":"D1","key":"10.1016\/j.ymthe.2021.02.021_bib43","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"Jassal","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2021.02.021_bib44","series-title":"R: a language and environment for statistical computing","year":"2020"},{"key":"10.1016\/j.ymthe.2021.02.021_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C5MB00663E","article-title":"ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization","volume":"12","author":"Yu","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ymthe.2021.02.021_bib46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.ymthe.2021.02.021_bib47","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.3390\/ijms21072418","article-title":"Chronic regulation of miR-124-3p in the perilesional cortex after experimental and human TBI","volume":"21","author":"Vuokila","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2021.02.021_bib48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13041-020-00653-x","article-title":"Genetic deletion of microRNA-22 blunts the inflammatory transcriptional response to status epilepticus and exacerbates epilepsy in mice","volume":"13","author":"Almeida Silva","year":"2020","journal-title":"Mol. Brain"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:05:10Z","timestamp":1778616310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001621000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1525001621000885"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.021","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}